Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
language:"Italian"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=language%3A%22Italian%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=language%3A%22Italian%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=language%3A%22Italian%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (22)
1
PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19) : PROTECT: A randomized study with Hydroxychloroquine versus observational support for prevention or early phase treatment of Coronavirus disease (COVID-19). - PROTECT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19) : PROTECT: A randomized study with Hydroxychloroquine versus observational support for prevention or early phase treatment of Coronavirus disease (COVID-19). - PROTECT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Studio per valutare la sicurezza e l'efficacia del selinexor vs. trattamento di scelta del medico in pazienti con mielofibrosi già precedentemente trattata. : A phase 2, randomized, open-label, multicenter study to evaluate safety and efficacy of single agent selinexor versus treatment of physician's choice in patients with previously treated myelofibrosis - XPORT-MF-035
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Studio per valutare la sicurezza e l'efficacia del selinexor vs. trattamento di scelta del medico in pazienti con mielofibrosi già precedentemente trattata. : A phase 2, randomized, open-label, multicenter study to evaluate safety and efficacy of single agent selinexor versus treatment of physician's choice in patients with previously treated myelofibrosis - XPORT-MF-035
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Nuovi end-points clinici in pazienti con sindrome di Sjögren primaria (pSS): uno studio interventistico basato sulla stratificazione dei pazienti. : NEw Clinical End-points in patients with primary Sjögren's Syndrome (pSS): an Interventional Trial based on stratifYing patients - NECESSITY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Nuovi end-points clinici in pazienti con sindrome di Sjögren primaria (pSS): uno studio interventistico basato sulla stratificazione dei pazienti. : NEw Clinical End-points in patients with primary Sjögren's Syndrome (pSS): an Interventional Trial based on stratifYing patients - NECESSITY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Studio degli effetti immuno-virologici dell’interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc : Studio degli effetti immuno-virologici dell’interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Studio degli effetti immuno-virologici dell’interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc : Studio degli effetti immuno-virologici dell’interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Studio per verificare efficacia, sicurezza e tollerabilità di bepranemab (UCB0107) in pazienti con deterioramento cognitivo o Malattia di Alzheimer (AD) lieve : A PATIENT- AND INVESTIGATOR-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPEN-LABEL EXTENSION PERIOD - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Studio per verificare efficacia, sicurezza e tollerabilità di bepranemab (UCB0107) in pazienti con deterioramento cognitivo o Malattia di Alzheimer (AD) lieve : A PATIENT- AND INVESTIGATOR-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPEN-LABEL EXTENSION PERIOD - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Sprache: Italienisch
Medienart
22
Aufsätze
22
E-Artikel
22
E-Ressourcen
Zeitschriftentitel
22
WHO International Clinical Trials Registry Plat...
Thema
22
610
Phase: Phase 2
22
Study Type: Interventional
14
Recruitment Status: Authorised-recruitment may ...
8
Recruitment Status: Not yet recruiting
2
Medical Condition: Alzheimer's Disease MedDRA v...
2
Medical Condition: Breast cancer - Stage 1-2 to...
2
Medical Condition: Children with medulloblastom...
2
Medical Condition: Early-stage (I [> 2 cm] to I...
2
Medical Condition: Group 1: SARS-CoV-2-exposed ...
2
Medical Condition: Hereditary Angioedema Type I...
2
Medical Condition: Myelofibrosis MedDRA version...
2
Medical Condition: Patients with arterial hyper...
2
Medical Condition: Primary Sjögren's syndrome ...
2
Medical Condition: Relapsed or Refractory CD30-...
2
Medical Condition: patients affected by HIV in ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
18
2020-
4
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Italienisch
Haven't found what you're looking for?
Wird geladen...